A Wee1 kinase inhibitor increased cytotoxicity of oncolytic adenoviruses in p53-deficient cells

被引:0
|
作者
Morinaga, T. [1 ]
Thao, N. T. [1 ,2 ]
Boya, Z. [1 ,2 ]
Tagawa, M. [1 ,2 ]
机构
[1] Chiba Canc Ctr, Res Inst, Div Pathol & Cell Therapy, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Dept Mol Biol & Oncol, Chiba, Japan
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P1329
引用
收藏
页码:256 / 256
页数:1
相关论文
共 50 条
  • [21] Enhancement of radiation response by the Aurora kinase inhibitor CYC116 in Ras mutant and p53-deficient cancer cells
    Leteur, Celine
    Tao, Yungan
    Deutsch, Eric
    Bourhis, Jean
    CANCER RESEARCH, 2009, 69
  • [22] An Inhibitor for the MDM2-p53 Interaction Produces Synergistic Cytotoxicity with Oncolytic Adenoviruses on Mesothelioma with Wild-Type p53 Genotype
    Tagawa, Masatoshi
    Nguyen, Thao T. T.
    Morinaga, Takao
    Zhong, Boya
    Hanazono, Michiko
    Kubo, Shuji
    Shingyoji, Masato
    Tada, Yuji
    Tatsumi, Koichiro
    Shimada, Hideaki
    Hiroshima, Kenzo
    MOLECULAR THERAPY, 2017, 25 (05) : 280 - 280
  • [23] A MDM2 inhibitor achieves synergistic cytotoxicity with oncolytic adenoviruses on mesothelioma with the wild-type p53
    Thi Thanh Thao Nguyen
    Zhong, Boya
    Morinaga, Takao
    Kubo, Shuji
    Sekine, Ikuo
    Tada, Yuji
    Tatsumi, Koichiro
    Shimada, Hideaki
    Hiroshima, Kenzo
    Tagawa, Masatoshi
    CANCER SCIENCE, 2018, 109 : 960 - 960
  • [24] MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective non-small cell lung cancer (NSCLC) cells
    Bridges, Kathleen
    Hirai, Hiroshi
    Buser, Carolyn
    Meyn, Raymond E.
    CANCER RESEARCH, 2010, 70
  • [25] Mitochondrial impairment in p53-deficient human cancer cells
    Zhou, S
    Kachhap, S
    Singh, KK
    MUTAGENESIS, 2003, 18 (03) : 287 - 292
  • [26] Preferential killing of p53-deficient cancer cells by reversine
    Jemaa, Mohamed
    Galluzzi, Lorenzo
    Kepp, Oliver
    Boileve, Alice
    Lissa, Delphine
    Senovilla, Laura
    Harper, Francis
    Pierron, Gerard
    Berardinelli, Francesco
    Antoccia, Antonio
    Castedo, Maria
    Vitale, Ilio
    Kroemer, Guido
    CELL CYCLE, 2012, 11 (11) : 2149 - 2158
  • [27] Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
    Dar, Altaf A.
    Belkhiri, Abbes
    Ecsedy, Jeffrey
    Zaika, Alexander
    El-Rifai, Wael
    CANCER RESEARCH, 2008, 68 (21) : 8998 - 9004
  • [28] P53-deficient cells display increased sensitivity to anthracyclines after loss of the catalytic subunit of the DNA-dependent protein kinase
    Fedier, A
    Moawad, A
    Haller, U
    Fink, D
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (05) : 1431 - 1437
  • [29] An MDM2 inhibitor produces cytotoxicity of oncolytic adenoviruses by increasing NF1 in mesothelioma with wild-type p53
    Thi Thanh Thao Nguyen
    Morinaga, Takao
    Zhong, Boya
    Kubo, Shuji
    Tada, Yuji
    Tatsumi, Koichiro
    Shimada, Hideaki
    Hiroshima, Kenzo
    Tagawa, Masatoshi
    CANCER SCIENCE, 2018, 109 : 1010 - 1010
  • [30] Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cells
    Wilsker, Deborah F.
    Chung, Jon H.
    Bunz, Fred
    CANCER RESEARCH, 2011, 71